跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-223
首页
药物
A-223
A-223
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Formulations of bendamustine
US 8609707 B2
申请人: PALEPU NAGESH R
优先权: 2011
US
16 件公开
US 2013210879 A1
申请人: EAGLE PHARMACEUTICALS INC
优先权: 2013
US
Peptide vaccines for cancers expressing tumor-associated antigens
US 8383590 B2
申请人: ONCOTHERAPY SCIENCE INC
优先权: 2009
US
10 件公开
GLYCOSYL-MODIFIED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL, AND USE
EP 4538296 A4
申请人: KAIMI BIOMEDICINE CHENGDU CO LTD
优先权: 2023
CN
EP
US
WO
8 件公开
Method and device for radiotherapy
US 8894969 B2
申请人: KELSON ITZHAK
优先权: 2004
US
8 件公开
Isotope purification method
US 10729794 B2
申请人: BAYER AS
优先权: 2016
CN
EP
US
WO
5 件公开
Transport peptides such as C-terminal Erns peptide and analogues thereof
US 7067487 B2
申请人: PEPSCAN SYSTEMS BV
优先权: 2000
US
4 件公开
FULVESTRANT FORMULATIONS
US 2013267489 A1
申请人: SCIDOSE LLC
优先权: 2013
US
4 件公开
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
US 10858403 B2
申请人: EVOGENE LTD
优先权: 2015
US
4 件公开
GLYCOSYLATED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL AND USE THEREOF
EP 4789681 A1
申请人: CHIMIGEN BIOMEDICAL CHENGDU CO LTD
优先权: 2024
CN
EP
WO
3 件公开
Isotope preparation method
EP 2733705 A1
申请人: ALGETA ASA
优先权: 2010
EP
US
3 件公开
WO 2017118591 A1
申请人: BAYER AS
优先权: 2016
CN
WO
2 件公开
EP 2854137 A1
申请人: ALGETA ASA
优先权: 2010
EP
第 1 / 9 页
上一页
下一页
药物
反馈